Population
Patients with nonalcoholic fatty liver disease (NAFLD) and experimental models
Design
Review
Authors
Loading...
Cytokine modulation merits exploration as NAFLD therapy; leaves open validation in prospective trials.
This review highlights the central role of pro-inflammatory cytokines and adiponectins in the progression of nonalcoholic fatty liver disease, suggesting potential therapeutic targets.
Hijona et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: